High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection
Pauline McDonagh Hull1, Bonnie M Lashewicz1, Marvin J Fritzler2
1Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
High intelligence quotient (IQ) may increase children's risk for severe COVID-19 complications, including multisystem inflammatory syndrome in children (MIS-C). Further research is needed to understand this potential psychoneuroimmunological vulnerability.
Area of Science:
- Pediatric Immunology
- Neuroscience
- Infectious Diseases
Background:
- The immune system's role in responding to SARS-CoV-2 infection is crucial.
- Multisystem inflammatory syndrome in children (MIS-C) is a severe COVID-19 complication.
- Children with high intelligence quotients (IQ) are hypothesized to be at increased risk.
Purpose of the Study:
- To investigate the hypothesis that high IQ may correlate with increased risk of severe COVID-19 sequelae in children.
- To explore potential immune dysregulation and psychoneuroimmunological vulnerabilities in high-IQ children post-SARS-CoV-2 infection.
Main Methods:
- Review of existing literature on autoimmunity and immune responses.
- Analysis of 27 pediatric severe COVID-19 cases from media reports (March-September 2020).
- Discussion of immune dysregulation, cytokine expression, and a 'hyper brain, hyper body' response.
Main Results:
- A review of 27 severe pediatric COVID-19 cases suggests a potential 'hyper brain, hyper body' response in high-IQ children.
- High-IQ children may face a greater risk for severe COVID-19 outcomes, including MIS-C.
- Immune dysregulation, particularly in the myocardium, is noted in some high-IQ pediatric patients.
Conclusions:
- The findings suggest a need for further prospective and retrospective studies on autoinflammatory markers in high-IQ children.
- Understanding potential psychoneuroimmunological vulnerabilities could inform prophylactic medical care strategies.
- This research adds a novel perspective to the understanding of COVID-19's impact on children.
Abstract:
The body's innate and acquiredimmunesystems are critical in responses to a wide spectrum of assaults, including SARS-CoV-2 infection. We identify studies of autoimmunity to support our hypothesis that a high intelligence quotient (IQ) may put children at increased risk for severe COVID-19 sequelae; especially those whose viral load is high and/or who develop multisystem inflammatory syndrome in children (MIS-C). MIS-C is associated with a higher risk of COVID-19 morbidity and death, even in otherwise healthy children. As information and evidence about SARS-CoV-2 infection continue to expand, our hypothesis suggests adding a potentially intriguing piece to the pandemic puzzle for further investigation. Drawing on a select review of published research and case reports, we discuss immune dysregulation in paediatric patients with a high IQ, including post-infection cytokine expression in the myocardium. Further, we provide a review of 27 paediatric (≤19 years; median age 16) cases of severe COVID-19 outcomes, drawn from media sources published between March and September 2020, in which we identify possible evidence of a 'hyper brain, hyper body' response to infection. We aver these cases are noteworthy given that paediatric death with COVID-19 disease is remarkably rare, and the estimated prevalence of a high IQ (or giftedness) is only 2% in the general population. These observations warrant prospective and retrospective studies of autoinflammatory markers and mechanisms to elucidate any special psychoneuroimmunological vulnerability in children with a high IQ, as such studies may raise implications for how and when prophylactic medical care is provided to children.
More Related Videos
Related Concept Videos
Biological Influences on Intelligence
Environmental Influences on Intelligence
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption


